e-learning
resources
Vienna 2012
Monday, 03.09.2012
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD
A. Sichelstiel, A. Trompette, K. Yadava, L. P. Nicod, B. J. Marsland (Lausanne, Switzerland)
Source:
Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session:
Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Session type:
Thematic Poster Session
Number:
2140
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sichelstiel, A. Trompette, K. Yadava, L. P. Nicod, B. J. Marsland (Lausanne, Switzerland). Targeting the IL-1β – IL-17A inflammatory axis for the treatment of viral-induced exacerbations of COPD. Eur Respir J 2012; 40: Suppl. 56, 2140
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
α-b crystallin – a marker for inflammation in COPD patients
Source: Annual Congress 2009 - Airway inflammation and host defence
Year: 2009
A model of poly IC-driven exacerbations of smoke-induced pulmonary inflammation – does it meet researchers needs?
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Heliox administration in patients with COPD exacerbation – Technical aspects
Source: Annual Congress 2010 - Mechanical ventilation and weaning
Year: 2010
Role of systemic inflammation mediated by IL-6 and TNF-alpha cytokines in chronic obstructive pulmonary disease and its progression: A three year follow up study
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
The level of anti-inflammatory cytokine IL-10 in patients with chronic obstructive pulmonary disease of varying severity
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Bacterial endotoxin-induced T-lymphocyte immune response is impaired in COPD – effect of moxifloxacin and dexamethasone
Source: Annual Congress 2009 - Inflammatory cells and cytokines
Year: 2009
Chronic non-asthmatic cough – Are we nearer to define the airway pathology?
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Altered inflammasome activity in bacterial acute exacerbations of COPD (AECOPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
β
2
long-acting and anticholinergic drugs synergistically control TGFβ1-mediated neutrophilic inflammation in COPD: An
"in vitro"
model
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Nontypeable
haemophilus influenzae leads to activation of the NLRP3 inflammasome – A possible trigger of chronic bronchial inflammation in COPD
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Reprogramming of alveolar macrophages – Prospect of successful treatment in COPD
Source: Annual Congress 2011 - Phagocytes and dendritic cells
Year: 2011
COPD exacerbation severity is associated with impaired macrophage phagocytosis of eosinophils
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Infectious exacerbations of COPD: IL-18 and its relation to markers of inflammation
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Interleukin-33 and Th2 cytokines correlate in acute asthma
Source: International Congress 2016 – Clinical and molecular studies in asthma
Year: 2016
Severe asthma: from inflammatory phenotype to treatment
Source: International Congress 2017 – Chinese Programme 2017
Year: 2017
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Erdosteine – A new drug in the treatment of chronic rhinosinusitis
Source: Annual Congress 2012 - Treatment of asthma, bronchiectasis and cough: inhaler use
Year: 2012
Comorbidities associated with chronic obstructive pulmonary disease (COPD) – A clinical study
Source: Annual Congress 2011 - COPD diagnosis
Year: 2011
Role of IL-1α and IL-1β in cigarette smoke-induced pulmonary inflammation and COPD
Source: Annual Congress 2011 - COPD: clinical studies and animal cell models
Year: 2011
Respiratory muscle function during and after a severe exacerbation of COPD – Preliminary results
Source: Annual Congress 2011 - Respiratory physiotherapy in the intensive care unit and on the ward: breathing exercises and respiratory muscles
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept